Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Incyte Corporation (INCY)

« Back to company index

INCY Chatter Timeline

Stock Ticker for INCY

Most Active Tweeters for INCY

UserTweets
@Tickeron 7
@ChartMill 4
@semodough 3
@TickerReport 3
@AlertTrade 2

Recent Tweets for INCY

LargeVoidBot @LargeVoidBot
Daily Reversal (10:07): $INCY Last: 78.41; pHigh: 78.17; rVol: 0.815; pClose: 76.43; LOD: 75.6300; Perf: 2.6%
10:09am
commander_x09 @commander_x09
RT @semodough: $INCY catalysts Results of REACH-2 & REACH 3 ph.III studies for full approval in acute GVHD & filing in chronic GVHD (2H19).…
9:09am
semodough @semodough
$INCY catalysts Results of REACH-2 & REACH 3 ph.III studies for full approval in acute GVHD & filing in chronic GVH… https://t.co/7G0ciOkZwi
9:09am
commander_x09 @commander_x09
RT @semodough: RBC $INCY See Balanced Setup into 2H19 GvHD Catalysts, with Higher-Impact Events Potentially in 2020-number of key catalysts…
9:09am
semodough @semodough
RBC $INCY See Balanced Setup into 2H19 GvHD Catalysts, with Higher-Impact Events Potentially in 2020-number of key… https://t.co/eBBDRDNTCo
9:09am
Tickeron @Tickeron
$INCY in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on January 24, 2019. View odds for thi… https://t.co/JwAzaPW7S6
8:09am
stocknewstimes @stocknewstimes
Incyte $INCY Research Coverage Started at BMO Capital Markets https://t.co/8fl7lCupeM
6:09am
Tickeron @Tickeron
$INCY in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on January 24, 2019. View odds for thi… https://t.co/ssU0MVmrjZ
September 15th 2019, 9:09pm
TickerReport @TickerReport
BMO Capital Markets Begins Coverage on Incyte $INCY https://t.co/pRhLRHduse
September 15th 2019, 2:09pm
TranscriptDaily @TranscriptDaily
BMO Capital Markets Begins Coverage on Incyte $INCY https://t.co/HS3E6NOuNp
September 15th 2019, 2:09pm
Gambiste1 @Gambiste1
RT @bs_marker: We're still looking for someone else who can beat our performances! Help us find them! RT please. $INCY Last close: 2019-09…
September 15th 2019, 9:09am
bs_marker @bs_marker
The first informative #App on Pivot Points. Stock: $INCY Last close: 2019-09-13 ($ 76.430) PIVOT POINT ------------… https://t.co/O0184XqpHN
September 15th 2019, 8:09am
bs_marker @bs_marker
We're still looking for someone else who can beat our performances! Help us find them! RT please. $INCY Last close… https://t.co/bQ6IpdiYUO
September 15th 2019, 8:09am
ChartMill @ChartMill
$INCY has a Quick Ratio of 5.59, indicating it is financially healthy. https://t.co/yiNP1tdKpY https://t.co/V39uPSctMr
September 15th 2019, 3:09am
MarketChmln @MarketChmln
$INCY upcoming event September 18: Bank of America Merrill Lynch Global Healthcare Conference. Options expiring on… https://t.co/1JK4wYqQXP
September 14th 2019, 9:09pm
ThisLincolnian @ThisLincolnian
BMO Capital Markets Begins Coverage on Incyte $INCY https://t.co/PSfrKvYERJ
September 13th 2019, 7:09pm
WeekHerald @WeekHerald
Incyte $INCY Receives New Coverage from Analysts at BMO Capital Markets https://t.co/Fplb85o5tJ
September 13th 2019, 7:09pm
tradnews_ @tradnews_
RT @AlertTrade: UP/DOWNGRADES ? $INCY: BMO Capital Markets starts at Market Perform https://t.co/wPmH29Hpto via ? https://t.co/VS8RO1bzXJ
September 13th 2019, 2:09pm
AlertTrade @AlertTrade
UP/DOWNGRADES ? $INCY: BMO Capital Markets starts at Market Perform https://t.co/wPmH29Hpto via ? https://t.co/VS8RO1bzXJ
September 13th 2019, 2:09pm
Briefingcom @Briefingcom
$INCY: BMO Capital Markets starts at Market Perform
September 13th 2019, 2:09pm
ActionTrading1 @ActionTrading1
$INCY 4 Hours https://t.co/Vn1EffNBnW
September 13th 2019, 2:09pm
Tickeron @Tickeron
$INCY in Uptrend: 50-day Moving Average broke above 200-day Moving Average on January 24, 2019. View odds for this… https://t.co/dLUapRVYOQ
September 13th 2019, 11:09am
ActionTrading1 @ActionTrading1
$INCY 4 Hours https://t.co/Fxk2Po0VBp
September 13th 2019, 8:09am
1MinuteStock @1MinuteStock
Recommendation #HOLD for $INCY with UB rating - 2.8 out of 5. https://t.co/dzBZTQNhOr
September 12th 2019, 11:09pm
1MinuteStock @1MinuteStock
Recommendation #HOLD for $INCY with UB rating - 2.7 out of 5. https://t.co/dzBZTQNhOr
September 12th 2019, 10:09pm
tstamm7002 @tstamm7002
$INCY getting whooped again
September 12th 2019, 12:09pm
Miljenkoz @Miljenkoz
Is there any other analyst with rating *upgrade*? $INCY
September 12th 2019, 12:09pm
Tickeron @Tickeron
$INCY in Uptrend: 50-day Moving Average broke above 200-day Moving Average on January 24, 2019. View odds for this… https://t.co/Gdo9huB6Td
September 12th 2019, 9:09am
AmericanBanking @AmericanBanking
BMO Capital Markets Begins Coverage on Incyte $INCY https://t.co/oleqUznaSN #stocks
September 12th 2019, 8:09am
AmericanBanking @AmericanBanking
Incyte Co. $INCY Receives Consensus Rating of “Buy” from Brokerages https://t.co/RIvDIls2ov #stocks
September 12th 2019, 6:09am
AlertTrade @AlertTrade
UP/DOWNGRADES ? $INCY: BMO Capital Markets starts at Market Perform https://t.co/1i4twPLfb4 via ? https://t.co/VS8RO1bzXJ
September 11th 2019, 7:09pm
confcalltran @confcalltran
Incyte Corporation's EVP %26 General Counsel just picked up 76 shares https://t.co/HLzsPC56Zf $INCY
September 11th 2019, 4:09pm
InsiderAlertsIA @InsiderAlertsIA
$INCY: New Insider Filing on EVP & General Counsel MARIA E PASQUALE: https://t.co/Cb5mn432co
September 11th 2019, 4:09pm
Tickeron @Tickeron
$INCY in Uptrend: 50-day Moving Average broke above 200-day Moving Average on January 24, 2019. View odds for this… https://t.co/8bpr2DgVRa
September 11th 2019, 9:09am
edtaussig @edtaussig
RT @semodough: $CALA and partner $INCY are scheduled to present INCB001158 (CB-1158 [arginase inhibitor]) Phase I clinical data in an oral…
September 11th 2019, 3:09am
TickerReport @TickerReport
Incyte Co. $INCY to Post Q3 2019 Earnings of $0.45 Per Share, Oppenheimer Forecasts https://t.co/A5pka3BpfF
September 11th 2019, 1:09am
WatchlistN @WatchlistN
$540.90 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/FpVdKXQeia
September 10th 2019, 10:09pm
ConsumerFeed @ConsumerFeed
Analysts Anticipate Incyte Co. $INCY Will Post Earnings of $0.65 Per Share https://t.co/PhyDHyb85G
September 10th 2019, 10:09pm
semodough @semodough
$CALA and partner $INCY are scheduled to present INCB001158 (CB-1158 [arginase inhibitor]) Phase I clinical data in… https://t.co/AwQNlmOc09
September 10th 2019, 9:09pm
Ogut_Ozgur @Ogut_Ozgur
fwiw $incy putting strong emphasis on the importance of the itacitinib gvhd reading for the company, and again stre… https://t.co/GX57F28GXS
September 10th 2019, 8:09pm
ChartMill @ChartMill
$INCY is growing strongly and shows a nice technical setup now! https://t.co/1qZp7ZnJqT
September 10th 2019, 6:09pm
Miljenkoz @Miljenkoz
$INCY Did someone recently upgraded INCY?
September 10th 2019, 3:09pm
Tickeron @Tickeron
$INCY in Uptrend: 50-day Moving Average broke above 200-day Moving Average on January 24, 2019. View odds for this… https://t.co/VY0TBecVsI
September 10th 2019, 9:09am
TickerReport @TickerReport
Incyte $INCY Cut to “Sell” at ValuEngine https://t.co/kutYdjjeaA
September 10th 2019, 5:09am
ChartMill @ChartMill
Our 'Technical Setups in Strongly Growing Stocks' lists $INCY today! https://t.co/1qZp7ZnJqT
September 10th 2019, 4:09am
ChartMill @ChartMill
A very nice breakout setup pattern for $INCY, will it break out? https://t.co/1qZp7ZnJqT
September 9th 2019, 9:09pm
Tickeron @Tickeron
$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on September 4, 2019. View odds for t… https://t.co/MvigxETFf3
September 9th 2019, 9:09am
Tickeron @Tickeron
$INCY in Uptrend: 50-day Moving Average moved above 200-day Moving Average on January 24, 2019. View odds for this… https://t.co/YPVp7Xo4NO
August 11th 2019, 7:08am
AlertTrade @AlertTrade
RT @SwingTradeBot: Recent $INCY technical alerts: Crossed Above 20 DMA plus 13 more alerts... https://t.co/w5vDMJe2Lv
August 10th 2019, 4:08pm
SwingTradeBot @SwingTradeBot
Recent $INCY technical alerts: Crossed Above 20 DMA plus 13 more alerts... https://t.co/w5vDMJe2Lv
August 10th 2019, 3:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.